186 related articles for article (PubMed ID: 7704184)
1. Altered ascorbic acid status in the mucosa from inflammatory bowel disease patients.
Buffinton GD; Doe WF
Free Radic Res; 1995 Feb; 22(2):131-43. PubMed ID: 7704184
[TBL] [Abstract][Full Text] [Related]
2. Depleted mucosal antioxidant defences in inflammatory bowel disease.
Buffinton GD; Doe WF
Free Radic Biol Med; 1995 Dec; 19(6):911-8. PubMed ID: 8582668
[TBL] [Abstract][Full Text] [Related]
3. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
4. Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease.
Sido B; Hack V; Hochlehnert A; Lipps H; Herfarth C; Dröge W
Gut; 1998 Apr; 42(4):485-92. PubMed ID: 9616308
[TBL] [Abstract][Full Text] [Related]
5. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.
Souza HS; Tortori CJ; Castelo-Branco MT; Carvalho AT; Margallo VS; Delgado CF; Dines I; Elia CC
Int J Colorectal Dis; 2005 May; 20(3):277-86. PubMed ID: 15503066
[TBL] [Abstract][Full Text] [Related]
7. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease.
Kruidenier L; Kuiper I; Van Duijn W; Mieremet-Ooms MA; van Hogezand RA; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):17-27. PubMed ID: 12950013
[TBL] [Abstract][Full Text] [Related]
8. Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease.
Keshavarzian A; Banan A; Farhadi A; Komanduri S; Mutlu E; Zhang Y; Fields JZ
Gut; 2003 May; 52(5):720-8. PubMed ID: 12692059
[TBL] [Abstract][Full Text] [Related]
9. Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease.
McKenzie SJ; Baker MS; Buffinton GD; Doe WF
J Clin Invest; 1996 Jul; 98(1):136-41. PubMed ID: 8690784
[TBL] [Abstract][Full Text] [Related]
10. Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
Zhang W; Teng G; Wu T; Tian Y; Wang H
Inflamm Bowel Dis; 2017 Dec; 23(12):2134-2141. PubMed ID: 29084078
[TBL] [Abstract][Full Text] [Related]
11. [Annexin A2 expression in intestinal mucosa of patients with inflammatory bowel disease and its clinical implications].
Zhang Z; Zhao X; Lv C; Li C; Zhi F
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1548-52. PubMed ID: 23174572
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
13. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease.
Carvalho AT; Elia CC; de Souza HS; Elias PR; Pontes EL; Lukashok HP; de Freitas FC; Lapa e Silva JR
J Clin Gastroenterol; 2003 Feb; 36(2):120-5. PubMed ID: 12544193
[TBL] [Abstract][Full Text] [Related]
15. Imbalance of the interleukin 1 system in colonic mucosa--association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2.
Andus T; Daig R; Vogl D; Aschenbrenner E; Lock G; Hollerbach S; Köllinger M; Schölmerich J; Gross V
Gut; 1997 Nov; 41(5):651-7. PubMed ID: 9414973
[TBL] [Abstract][Full Text] [Related]
16. Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease.
Magro F; Vieira-Coelho MA; Fraga S; Serrão MP; Veloso FT; Ribeiro T; Soares-da-Silva P
Dig Dis Sci; 2002 Jan; 47(1):216-24. PubMed ID: 11837726
[TBL] [Abstract][Full Text] [Related]
17. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease.
Wehkamp J; Fellermann K; Herrlinger KR; Baxmann S; Schmidt K; Schwind B; Duchrow M; Wohlschläger C; Feller AC; Stange EF
Eur J Gastroenterol Hepatol; 2002 Jul; 14(7):745-52. PubMed ID: 12169983
[TBL] [Abstract][Full Text] [Related]
18. Impact of smoking cigarette on the mRNA expression of cytokines in mucosa of inflammatory bowel disease.
Vrablicova Z; Soltys K; Krajcovicova A; Stuchlikova K; Sturdik I; Koller T; Huorka M; Payer J; Killinger Z; Jackuliak P; Tkacik M; Stuchlik S; Sekac J; Hlavaty T
Physiol Res; 2019 Nov; 68(Suppl 2):S183-S192. PubMed ID: 31842582
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn's disease and ulcerative colitis.
Berndt U; Bartsch S; Philipsen L; Danese S; Wiedenmann B; Dignass AU; Hämmerle M; Sturm A
J Immunol; 2007 Jul; 179(1):295-304. PubMed ID: 17579049
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease.
Breese EJ; Michie CA; Nicholls SW; Murch SH; Williams CB; Domizio P; Walker-Smith JA; MacDonald TT
Gastroenterology; 1994 Jun; 106(6):1455-66. PubMed ID: 8194690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
